HOME >> MEDICINE >> NEWS
Inflammatory bowel disease doubles risk of pregnancy complications

Inflammatory bowel disease roughly doubles the chances of pregnancy complications, reveals research published ahead of print in Gut.

Inflammatory bowel disease, or IBD for short, is an umbrella term for the inflammatory disorders of Crohn's disease and ulcerative colitis.

The research team re-analysed 12 studies published over the past 20 years, which assessed the impact of IBD on pregnancy and birth.

In all, the dozen studies, drawn from an extensive search of published material, involved almost 4000 women with IBD and more than 320, 000 people without the condition, with whom they were compared.

Around two thirds of the women had Crohn's disease; the remainder had ulcerative colitis.

The results showed that women with IBD were almost twice as likely to have a child born prematurely, and more than twice as likely to have a child born below normal weight.

Premature and low birthweight babies run the risk of developmental problems and a greater likelihood of serious chronic illness.

Women with IBD were 1.5 times as likely to have had a caesarean section as their healthy peers, especially those with Crohn's disease.

And the rate of congenital birth defects in babies born to mothers with IBD was more than twice as high.

If a woman becomes pregnant during an active bout of disease the risks of pregnancy complications are likely to be greater, suggest the authors.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ Specialty Journals
20-Dec-2006


Page: 1

Related medicine news :

1. Inflammatory system genes linked to cognitive decline after heart surgery
2. Inflammatory processes in arteriosclerosis revealed
3. Crohns & Colitis Foundation of America selects Wiley to publish Inflammatory Bowel Diseases
4. Inflammatory biomarker helps identify progressive precancerous lesions in the lung
5. Inflammatory markers may help predict stroke risk in middle-aged people
6. Clinical review -- A psychological approach to the management of irritable bowel syndrome
7. New prevention, treatment methods for patients with painful bowel inflammation
8. New treatments needed for irritable bowel syndrome
9. Restricted fetal growth increases risk of irritable bowel syndrome
10. Risk of infertility in women triples after common inflammatory bowel disease surgery
11. New compounds fight chronic symptoms of bowel disorders

Post Your Comments:
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 Jury ... nation’s first trial involving a da Vinci lawsuit, ... case, the family of a man who allegedly died of ... more than $8 million in damages from Intuitive Surgical, Inc. ... its physician training program for the da Vinci Surgical System ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Nearly 50,000 ... Appeals (BVA) in fiscal year 2012, with even more—54,033—expected ... waiting longer for a decision as the agency reports ... which provides veterans disability appeal services. The ... Veterans Affairs. , Although the BVA received 49,611 cases ...
(Date:5/22/2013)... Ore. A new study shows there is a ... in American young children one that does not ... the United States, girls had higher levels of self-regulation ... control their behavior and impulses, follow directions, and persist ... performance and college completion, in past studies by Oregon ...
(Date:5/22/2013)... Los Angeles, CA (PRWEB) May 22, 2013 ... therapy4parents.com , hosted by Patricia O’Laughlin Psychotherapy in ... now seeing people of all ages as progression ... “Including children of all ages into parenting therapy ... Patricia O’Laughlin emphasizes. Patricia O’Laughlin Psychotherapy now specializes ...
(Date:5/22/2013)... Diversity Focus and Handicap This Productions announce ... promotes awareness that physical disabilities do not stop people ... be held Friday, June 14th at 7:30 p.m. at ... Handicap This! can be purchased at http://www.diversityfocus.org . ... to which their mind is handicap accessible. Mike ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:Handicap This! Comes to Marion, Iowa 2
(Date:5/22/2013)... NEW YORK , May 22, 2013  Ohr ... the development of novel therapeutics for unmet medical needs, ... Almenoff , M.D., Ph.D., to its Board of ... industry, working on early and late stage drug development. ... Almenoff join Ohr,s Board," said Dr. Irach Taraporewala, CEO ...
(Date:5/22/2013)... May 22, 2013 Varian Medical Systems ... received 510(k) clearance from the U.S. Food and ... processing workstation that combines radio frequency (RF) and ... Nexus DRF Digital X-Ray Imaging System™ has the ... receptors, including CCD cameras and commercially available flat-panel ...
(Date:5/22/2013)... Ambit Biosciences Corporation (Nasdaq: AMBI ... quizartinib (AC220), a potent and selective FLT3 inhibitor, will ... Society of Clinical Oncology, held May 31 through June ... . Information about the abstracts, ... can be viewed online at http://abstracts2.asco.org/ . Abstract ...
Breaking Medicine Technology:Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 2Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 3
Cached News: